Talaria Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Talaria Asset Management's PFE Position: Q2 2026 in Review
Talaria Asset Management reduced its Pfizer (PFE) stake by 7% in Q2 2026, selling an estimated $3.24M and leaving 1,656,200 shares worth $39.9M. The position accounts for 8.53% of the portfolio, ranked #5.
Talaria Asset Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $50M in Q1 2026. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Talaria Asset Management held 1,656,200 shares of Pfizer worth $39.9M as of Q2 2026.
- Talaria Asset Management sold 123,900 Pfizer shares in Q2 2026, an estimated $3.24M.
- Pfizer made up 8.53% of Talaria Asset Management's portfolio in Q2 2026, its #5 holding.
- Talaria Asset Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
- Talaria Asset Management's Pfizer position peaked at $50M in Q1 2026.
- 2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Talaria Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.